Clinical Research Directory
Browse clinical research sites, groups, and studies.
Observational Real-life Study of Cabozantinib in Monotherapy or in Combination With Nivolumab in Advanced Renal Cell Carcinoma (RCC)
Sponsor: Ipsen
Summary
The purpose of this study is to describe the real-life use of Cabometyx® in monotherapy or in combination with nivolumab in Belgium in patients with advanced or metastatic Renal Cell Carcinoma (1st, 2nd and later lines of treatment)
Official title: REPLICA: Real Patient Life Treatment With Cabozantinib in Monotherapy or in Combination With Nivolumab in Patients With Advanced or Metastatic RCC: a Descriptive and Prospective Non Interventional Study.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
150
Start Date
2020-03-03
Completion Date
2027-03-31
Last Updated
2026-03-31
Healthy Volunteers
No
Locations (20)
Onze-Lieve-vrouw Ziekenhuis Aalst
Aalst, Belgium
Imeldaziekenhuis
Bonheiden, Belgium
Clinique Saint-Luc Bouge
Bouge, Belgium
AZ Sint-Jan Brugge
Bruges, Belgium
AZ Sint-Lucas
Bruges, Belgium
UZ Brussel
Brussels, Belgium
Ziekenhuis Oost-Limburg Genk
Genk, Belgium
Universitair Ziekenhuis Gent
Ghent, Belgium
Hôpital de Jolimont
La Louvière, Belgium
CHC MontLegia
Liège, Belgium
CHR Citadelle Liège
Liège, Belgium
CHU Liège / Sart-Tilman
Liège, Belgium
Hôpital Ambroise-Paré Mons
Mons, Belgium
CHU Charleroi - site André Vésale
Montigny-le-Tilleul, Belgium
Clinique Saint-Pierre
Ottignies, Belgium
AZ Delta
Roeselare, Belgium
AZ Glorieux
Ronse, Belgium
CHWAPI
Tournai, Belgium
AZ Turnhout
Turnhout, Belgium
CHR Verviers
Verviers, Belgium